Noteworthy

Clearing the Hurdles to a Career in Venture Capital

July 23, 2020

Dr. Geeta Vemuri, founder of biopharma investment firm Agent Capital, talks about sustaining a career in the venture capital sector.

Strategic Realignment for a Better Future

July 21, 2020

In adjusting to the long-term side-effects of the coronavirus pandemic, pharma companies will need to focus on change in three areas. Ben van der Schaaf and Aurelien Guichard report.

Launching during Lockdown

July 21, 2020

Immunomedics’ CFO/CBO Usama Malik discusses how a lot of good planning and a little good fortune helped the company to achieve its “virtual launch” amid the coronavirus crisis.

Patient Information Labeling and COVID-19

July 20, 2020

In recent months, many pharma businesses have pivoted to entirely new product lines against a backdrop of unprecedented disruption to the supply chain. Gurdip Singh provide pointers to ensure companies are ready to adapt to change.

Pharm Exec's Top 50 Companies 2020

July 09, 2020

Pharmaceutical Executive

Our 20th annual listing highlights brand surges, new ranking battles, and M&A-sparked upswings, but in the shadow of COVID-19, a peek behind the numbers also tells another story.

Virtual Hiring of the C-Suite

July 08, 2020

Pharmaceutical Executive

How COVID-19 has changed high-level recruitment.

A Sustainable Response to COVID-19

July 07, 2020

Pharmaceutical Executive

Three areas critical to ensuring meaningful long-term action.

Big Events Go Virtual: A Look Inside One Transformation

July 06, 2020

Pharmaceutical Executive

The transition from in-person was challenging, but meetings like DIA’s global event could explore formal hybrid models in the future.

Enterprise Leadership: Is Compliance Ripe for Disruption?

July 01, 2020

Pharmaceutical Executive

Case study illustrates how compliance teams, in today’s climate, can foster innovation across an organization to help achieve corporate goals.

Leverage Compliance Activities to Drive Data-Driven Success

June 26, 2020

Xavier Duburcq describes how pharma leaders can convert compliance from a cost center to a critical success factor.